Company intelligence / Profile preview

XableCath

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

XableCath has received multiple FDA clearances for its peripheral arterial catheters, including blunt tip and abrasion tip configurations. The company's catheters have demonstrated safe and effective crossing of challenging lesions in both arterial chronic total occlusions and chronic obstructive venous lesions. Clinical validation studies on 26 patients showed no procedural complications attributable to the XableCath Support Catheter, with successful traversal of 80 arterial segments.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on XableCath.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XableCath.

Explore the full profile